These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32948302)

  • 1. Transplantation of viable mitochondria improves right ventricular performance and pulmonary artery remodeling in rats with pulmonary arterial hypertension.
    Hsu CH; Roan JN; Fang SY; Chiu MH; Cheng TT; Huang CC; Lin MW; Lam CF
    J Thorac Cardiovasc Surg; 2022 May; 163(5):e361-e373. PubMed ID: 32948302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 improves cardiovascular function and survival in flow-induced pulmonary hypertension.
    Roan JN; Hsu CH; Fang SY; Tsai HW; Luo CY; Huang CC; Lam CF
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1661-1669.e4. PubMed ID: 29249493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Improvement and Regression of Medial Hypertrophy in the Remodeled Pulmonary Artery after Correction of Systemic Left-to-Right Shunt.
    Hsu CH; Roan JN; Chen JH; Lam CF
    Sci Rep; 2016 Nov; 6():37684. PubMed ID: 27886226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
    Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
    Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism.
    Guo Y; Liu X; Zhang Y; Qiu H; Ouyang F; He Y
    Life Sci; 2020 Sep; 256():118009. PubMed ID: 32603819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viable Allogeneic Mitochondria Transplantation Improves Gas Exchange and Alveolar-Capillary Permeability in Rats with Endotoxin-Induced Acute Lung Injuries.
    Pang YL; Fang SY; Cheng TT; Huang CC; Lin MW; Lam CF; Chen KB
    Int J Med Sci; 2022; 19(6):1036-1046. PubMed ID: 35813297
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoracic bilateral sympathectomy attenuates oxidative stress and prevents ventricular remodelling in experimental pulmonary hypertension.
    Coutinho E Silva RDS; Wiggenhauser LM; Simas R; Zanoni FL; Medeiros G; da Silva FB; Ogata DC; Breithaupt-Faloppa AC; Krenning G; Moreira LFP
    Eur J Cardiothorac Surg; 2022 May; 61(6):1337-1345. PubMed ID: 34957507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular and pulmonary vascular remodeling induced by pulmonary overflow in a chronic model of pretricuspid shunt.
    Linardi D; Rungatscher A; Morjan M; Marino P; Luciani GB; Mazzucco A; Faggian G
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2609-17. PubMed ID: 24908349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drag-reducing polymers attenuates pulmonary vascular remodeling and right ventricular dysfunction in a rat model of chronic hypoxia-induced pulmonary hypertension.
    Wang Y; Wu F; Hu F; Wu Y; Zhou J; Xu Y; Shao X; Hu T
    Clin Hemorheol Microcirc; 2020; 74(2):189-200. PubMed ID: 31476149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early treatment with hepatocyte growth factor improves pulmonary artery and right ventricular remodeling in rats with pulmonary artery hypertension by modulating cytokines expression].
    Wang X; Wang Y; Rong S; Ma H
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):427-32. PubMed ID: 25200042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation.
    Yoshida H; Kitaichi T; Urata M; Kurobe H; Kanbara T; Motoki T; Kitagawa T
    Ann Thorac Surg; 2009 Aug; 88(2):418-24. PubMed ID: 19632386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
    Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
    Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celastrol attenuates the remodeling of pulmonary vascular and right ventricular in monocrotaline-induced pulmonary arterial hypertension in rats.
    Li H; Liu Q; Yue Y; Wang S; Huang S; Huang L; Luo L; Zhang Y; Wu Z
    Cardiovasc Diagn Ther; 2022 Feb; 12(1):88-102. PubMed ID: 35282664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shikonin improves pulmonary vascular remodeling in monocrotaline‑induced pulmonary arterial hypertension via regulation of PKM2.
    Li W; Chen W; Peng H; Xiao Z; Liu J; Zeng Y; Huang T; Song Q; Wang X; Xiao Y
    Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36734266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Anti-Inflammatory Effects and Clinical Potential of Dexmedetomidine in Pulmonary Arterial Hypertension.
    Yamaguchi Y; Hosokawa S; Haraguchi G; Kajikawa Y; Sakurai M; Ishii T; Ando N; Morio T; Doi S; Furukawa T
    J Pharmacol Exp Ther; 2023 May; 385(2):88-94. PubMed ID: 36849413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.